NOT-FD-13-006: Notice to Change Funds Available and Award Budget for RFA-FD-13-013 Systematic Evaluation of Excipient Effects on the Efficacy of Metered Dose Inhaler Products (U01)

Notice to Change Funds Available and Award Budget for RFA-FD-13-013 " Systematic Evaluation of Excipient Effects on the Efficacy of Metered Dose Inhaler Products (U01)

Notice Number: NOT-FD-13-006

Key Dates
Release Date: May 22, 2013

Related Notices
RFA-FD-13-013

Issued by
Food and Drug Administration

Purpose

To inform potential applicants that there has been a change in the amount of Funds Available and the Award Budget information in Section II. Award Information of RFA-FD-13-013, "Systematic Evaluation of Excipient Effects on the Efficacy of Metered Dose Inhaler Products (UO1).

CURRENTLY READS:
Funds Available and Anticipated Number of Awards - The anticipated funds available are $500,000. Only one award will be made.

Award Budget-The anticipated funds available are $500,000. Awards are contingent upon the availability of funds. Application budgets are not limited, but need to reflect the actual needs of the proposed project.

CHANGED TO READ:
Funds Available and Anticipated Number of Awards - The anticipated funds available are $700,000. Only one award will be made.

Award Budget-The anticipated funds available are $700,000. Awards are contingent upon the availability of funds. Application budgets are not limited, but need to reflect the actual needs of the proposed project.

Inquiries

Please direct all inquiries to:

Gladys Melendez-Bohler
Grants Management Officer/Specialist
Food and Drug Administration
5630 Fishers Lane, Rm. 2032, HFA 500, Rockville, MD 20857
Telephone: 301-827-7175
Email: gladys.bohler@fda.hhs.gov